Article
Lexington, KY-One of the newest viscoelastic products approved by the FDA is 1.2% sodium hyaluronate (CoEase, Advanced Medical Optics), which exemplifies the trend toward developing agents with both dispersive and cohesive properties.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.